<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Aggressive B-cell <z:hpo ids='HP_0002665'>lymphomas</z:hpo> are occurring with increasing incidence among individuals infected with human <z:hpo ids='HP_0002721'>immunodeficiency</z:hpo> virus (HIV) </plain></SENT>
<SENT sid="1" pm="."><plain>Several lines of evidence implicate both Epstein-Barr virus (EBV) and c-myc activation in the pathogenesis of a major subset of these <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>These observations prompted our investigation of interactions among EBV, c-myc, and HIV in primary B cells </plain></SENT>
<SENT sid="3" pm="."><plain>We show that nonimmortalized peripheral B lymphocytes from EBV-seropositive, HIV-seronegative donors can be infected by HIV and that a subset of these lymphocytes become transformed </plain></SENT>
<SENT sid="4" pm="."><plain><z:e sem="disease" ids="C1608408" disease_type="Neoplastic Process" abbrv="">Malignant transformation</z:e> was documented by several criteria </plain></SENT>
<SENT sid="5" pm="."><plain>These cells displayed altered growth properties, propagating in 1% serum and cloning in soft agar, and formed invasive <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> of Burkitt <z:hpo ids='HP_0002665'>lymphoma</z:hpo> phenotype after subcutaneous injection into <z:hpo ids='HP_0004430'>severe combined immunodeficiency</z:hpo> mice </plain></SENT>
<SENT sid="6" pm="."><plain>Such cells revealed marked enhancement of EBV DNA and <z:chebi fb="40" ids="33697">RNA</z:chebi> and of endogenous c-myc transcripts and protein </plain></SENT>
<SENT sid="7" pm="."><plain>HIV-1 infection of already immortalized B-cell lines led to a similar upregulation of EBV and c-myc transcripts </plain></SENT>
<SENT sid="8" pm="."><plain>These data indicate that HIV has properties of a transforming retrovirus, as it mediates two events linked to B-cell <z:hpo ids='HP_0002664'>neoplasia</z:hpo>: deregulation of c-myc and activation of EBV </plain></SENT>
<SENT sid="9" pm="."><plain>They also raise the possibility of a role for HIV, apart from induction of immune suppression, in the pathogenesis of B-cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> in the acquired <z:hpo ids='HP_0002721'>immune deficiency</z:hpo> syndrome </plain></SENT>
</text></document>